Transcription of 40造血細胞移植 Program 1211 - congre.co.jp
{{id}} {{{paragraph}}}
Example: marketing
40造血細胞移植 Program 1211 - congre.co.jp
17 2 2 2 2-3-1 191 3 2 2 2 9:00 10:00 GVHD GVHD basic research O2-3-1 1 T Analysis of "minimal residual recipient T cells" after allo-HSCT by high-throughput sequencing 1 1 2 2 2 2 2 2 2 1 1 3 4 5 1 1 2 3 4 5 O2-3-1 2 Exosome Exosome Derived from Human Umbilical Cord and Amnion: Comparison of Immunosuppressive Ability 1 2, 3 1 1 1 1 2, 3 1 3 1 1 2 3 O2-3-1 3 5- GVHD Visible Light-based Photodynamic Therapy for Graft-versus-Host Disease O2-3-1 4 Inhibitors of apoptosis proteins IAPs are required for protecting gastrointestinal GVHD Tomomi Toubai1, 2 , Corinne Rossi3 , Katherine Oravecz-Wilson3 , Cynthia Zajac3 , Liu Chen4 , Hiroya Tamaki5 , Kenichi Ishizawa1 , Pavan Reddy3 1 The Third Department of Internal Medicine, Division of Hematology and Cell Therapy, Yamagata University2 Department of Internal Medicine, Division of Hematology and Oncology, Univ
－18－ 一般口演2-3-2 抄録：192ページ 第3会場（ロイトン札幌 2階 エンプレスホール） 2月2日（金） 10:10～11:10 座長：福田 隆浩（国立がん研究センター中央病院 造血幹細胞移 …
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: